Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

78.09
-0.9400-1.19%
Post-market: 78.090.00000.00%19:30 EDT
Volume:710.97K
Turnover:55.55M
Market Cap:3.43B
PE:-72.14
High:79.10
Open:78.67
Low:77.33
Close:79.03
52wk High:91.53
52wk Low:51.57
Shares:43.88M
Float Shares:35.64M
Volume Ratio:1.21
T/O Rate:1.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.88
PE(LYR):-49.11

Loading ...

Rxsight Names Aziz Mottiwala CEO, Ron Kurtz to Become Chief Medical Officer

Reuters
·
Jul 16

Tarsus Pharmaceuticals Announces Chief Commercial Officer Transition

TIPRANKS
·
Jul 14

Tarsus Pharmaceuticals chief commercial officer Aziz Mottiwala to depart

TIPRANKS
·
Jul 14

Tarsus CCO Aziz Mottiwala Departs; Neera Clase Named Interim Replacement

Reuters
·
Jul 14

Press Release: Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth

Dow Jones
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Conmed (CNMD) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 13

Guggenheim Sticks to Its Buy Rating for Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 13

Tarsus Pharmaceuticals Price Target Maintained with a $88.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 09

Tarsus Publishes Investor Presentation on Irenix Acquisition, Irx-101 Ocular Antiseptic Program

Reuters
·
Jul 09

Tarsus Pharmaceuticals Buys Irenix Medical in Deal with USD 75 Million Upfront Payment

Reuters
·
Jul 09

Tarsus Pharmaceuticals - Upfront Consideration for Deal Totals $75 Mln: $37.5 Mln Cash, $37.5 Mln Stock

THOMSON REUTERS
·
Jul 09

Tarsus Pharmaceuticals - to Begin Phase 3 Irx-101 Study in H1 2027, Results Expected 2028

THOMSON REUTERS
·
Jul 09

Tarsus Advances Eye Care Leadership Strategy with Acquisition of Irenix Medical and Late-stage Asset Irx-101

THOMSON REUTERS
·
Jul 09

Tarsus Pharmaceuticals - Potential Milestone Payments up to $490 Mln

THOMSON REUTERS
·
Jul 09

Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101

GlobeNewswire
·
Jul 09

Culper Research Says We are Short Tarsus Pharmaceuticals

Reuters
·
Jul 07

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jul 06

Analysts Offer Insights on Healthcare Companies: BrightSpring Health Services, Inc. (BTSG) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 02

Tarsus Pharmaceuticals Stock Drops as Short Seller Alleges Illegal Copay Scheme

Benzinga
·
Jul 02